{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:21:25Z","timestamp":1786119685381,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/mbc.0b013e32834512c0","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T04:44:12Z","timestamp":1300337052000},"page":"331-333","source":"Crossref","is-referenced-by-count":1,"title":["Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate\/ethinylestradiol treatment for polycystic ovary syndrome: a case report"],"prefix":"10.1097","volume":"22","author":[{"given":"Yunus","family":"Nazli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"Colak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer N","family":"Aksoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Cakir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-14-20210203","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1742-1241.1997.tb11478.x","article-title":"Central retinal vein occlusion associated with the polycystic ovarian syndrome","volume":"51","author":"Salzmann","year":"1997","journal-title":"Int J Clin Pract"},{"key":"R3-14-20210203","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"key":"R4-14-20210203","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-0038-1642480","article-title":"Thrombotic risk of women with hereditary antithrombin III-, protein C- and protein S-deficiency taking oral contraceptive medication: the GTH Study Group on Natural Inhibitors","volume":"71","author":"Pabinger","year":"1994","journal-title":"Thromb Haemost"},{"key":"R5-14-20210203","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1160\/TH09-01-0013","article-title":"The genetics of venous thromboembolism. A meta-analysis involving approximately 120 000 cases and 180 000 controls","volume":"102","author":"Gohil","year":"2009","journal-title":"Thromb Haemost"},{"key":"R6-14-20210203","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0140-6736(98)10266-0","article-title":"Venous thrombosis: a multicausal disease","volume":"353","author":"Rosendaal","year":"1999","journal-title":"Lancet"},{"key":"R7-14-20210203","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/01443610400007810","article-title":"Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors","volume":"24","author":"Lakhani","year":"2004","journal-title":"J Obstet Gynaecol"},{"key":"R8-14-20210203","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/09513590701237290","article-title":"Pseudotumor cerebri from sinus venous thrombosis, associated with polycystic ovary syndrome and hereditary hypercoagulability","volume":"23","author":"Finsterer","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"R9-14-20210203","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archinte.160.1.49","article-title":"Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects","volume":"160","author":"Bloemenkamp","year":"2000","journal-title":"Arch Intern Med"},{"key":"R10-14-20210203","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/01.mbc.0000175478.46831.52","article-title":"Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR G677A among 594 thrombotic Jordanian patients","volume":"16","author":"Eid","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R11-14-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1159\/000056296","article-title":"Methylenetetrahydrofolate reductase C677T genotype and venous thromboembolic disease","volume":"67","author":"Couturaud","year":"2000","journal-title":"Respiration"},{"key":"R12-14-20210203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000052117","article-title":"Mutation in the methylenetetrahydrofolate reductase gene might be a risk factor for cerebrovascular disease in peripartum and under oral contraceptive use","volume":"45","author":"Korn-Lubetzki","year":"2001","journal-title":"Eur Neurol"},{"key":"R13-14-20210203","first-page":"824","article-title":"C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients","volume":"84","author":"Gemmati","year":"1999","journal-title":"Haematologica"},{"key":"R14-14-20210203","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"Den Heijer","year":"1996","journal-title":"N Engl J Med"},{"key":"R15-14-20210203","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.ejcn.1601729","article-title":"Effects of the interaction between the C677T 5,10-methylenetetrahydrofolate reductase polymorphism and serum B vitamins on homocysteine levels in pregnant women","volume":"58","author":"Kim","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"R16-14-20210203","first-page":"358","article-title":"Screening for a prothrombotic diathesis in patients attending family planning clinics","volume":"112","author":"Kalev","year":"1999","journal-title":"N Z Med J"},{"key":"R17-14-20210203","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.1994.tb04920.x","article-title":"The family history and inherited thrombophilia","volume":"87","author":"Bri\u00ebt","year":"1994","journal-title":"Br J Haematol"},{"key":"R18-14-20210203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1378\/chest.126.3_suppl.401S","article-title":"Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Buller","year":"2004","journal-title":"Chest"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-201106000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:55:08Z","timestamp":1786042508000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-201106000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32834512c0","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}